Next Generation News and Research

RSS

Albumedix Expands Production Capacity at its Commercial-Scale Recombinant Human Albumin Manufacturing Plant and Opens New Research Facilities

Albumedix Ltd. ('Albumedix'), a recognized global leader in recombinant human albumin specializing in the enablement of advanced therapies, announces the completed expansion of the company’s commercial-scale manufacturing facility, alongside with the establishment of a new Technology Centre equipped with state-of-the-art laboratories at its UK-based campus in Nottingham.

From Albumedix Ltd. 13 Apr 2021

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

In a recent bioRxiv* preprint, the large team of researchers evaluated a SARS-CoV-2 Spike receptor-binding domain ferritin nanoparticle protein vaccine (RFN) in a nonhuman primate challenge model. This study addresses the need for a next-generation, efficacious vaccine with an increased pan-SARS breadth of coverage.

13 Apr 2021

Study finds correlation between COVID-19 pandemic and six unhealthy eating behaviors

A new probe into the lingering impacts of the COVID-19 pandemic revealed correlations to six unhealthy eating behaviors, according to a study by the University of Minnesota Medical School and School of Public Health.

12 Apr 2021

Researchers work to develop dual antigen COVID-19 vaccine candidate

A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.

12 Apr 2021

More than 100 economies receive life-saving COVID-19 vaccines from COVAX

More than one hundred economies have received life-saving COVID-19 vaccines from COVAX, the global mechanism for equitable access to COVID-19 vaccines. The milestone comes 42 days after the first COVAX doses were shipped and delivered internationally, to Ghana on 24 February 2021.

12 Apr 2021

CD40 drug before surgery can benefit patients with early-stage pancreatic cancer

Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center (ACC) at the University of Pennsylvania.

12 Apr 2021

Broadly neutralizing antibodies show promise in preventing tick-borne encephalitis in mice

Tick-borne encephalitis is a disease just as nasty as it sounds. Once bitten by an infected tick, some people develop flu-like symptoms that resolve quietly but leave behind rampant neurological disease--brain swelling, memory loss, and cognitive decline.

9 Apr 2021

SFU mathematics professor to lead new infectious disease modeling network

Simon Fraser University mathematics professor Caroline Colijn will lead a new, national infectious disease modeling network that will inform decisions related to public health threats and better prepare Canada for future pandemics.

9 Apr 2021

Scientists compare DNA damaging properties of chemicals from vape products and cigarettes

Imperial Brands scientists have utilized Toxys' ToxTracker suite of stem-cell based in-vitro assays, which provide mechanistic insight into the potential DNA damaging properties of chemicals, comparing vape e-liquid samples and their aerosols to combustible cigarette smoke.

9 Apr 2021

Intermountain partners with University of Utah to jointly develop new medical educational program

Intermountain Healthcare is working on a transformative model for the future of healthcare called population health that focuses on keeping people in communities healthy and pre-emptively addressing cause of illnesses, rather than just treating people when they are sick.

9 Apr 2021

New technique can make X-rays more efficient at diagnosing bone and other injuries

A novel way to pinpoint and illuminate bone damage promises to make X-rays more efficient at diagnosing bone and other injuries, Flinders University researchers say.

9 Apr 2021

More new SARS-CoV-2 variants are highly likely

In a recent report posted to the bioRxiv preprint server, researchers from the United Kingdom and Uganda reveal unique protein features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relative to other representatives of Sarbecoviruses.

8 Apr 2021

Study: H2AK119ub1 is necessary for maternal inheritance of H3K27me3

An epigenetic study at the RIKEN Center for Integrative Medical Sciences shows that in mouse egg cells, modifications to histone H2A at lysine 119 lay the groundwork for inherited DNA functional modifications from the mother.

8 Apr 2021

Solvation cages may lead to more efficient operation of high-voltage battery cells

Membranes that allow certain molecules to quickly pass through while blocking others are key enablers for energy technologies from batteries and fuel cells to resource refinement and water purification.

8 Apr 2021

Researchers develop innovative tough gel sheathed sutures inspired by human tendons

Sutures are used to close wounds and speed up the natural healing process, but they can also complicate matters by causing damage to soft tissues with their stiff fibers. To remedy the problem, researchers from Montreal have developed innovative tough gel sheathed (TGS) sutures inspired by the human tendon.

8 Apr 2021

Addiction experts seek to understand why people engage in 'extreme' drinking

It's a health crisis often hidden in plain sight. While binge drinking behaviors -- drinking alcohol to a blood alcohol concentration level of 0.08% or higher -- have been studied before, relatively little research has focused on people's behaviors and the consequences surrounding "extreme" drinking, or drinking alcohol to a blood alcohol concentration level of more than 0.16%.

7 Apr 2021

Next Generation News and Research

Albumedix Expands Production Capacity at its Commercial-Scale Recombinant Human Albumin Manufacturing Plant and Opens New Research Facilities

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

Study finds correlation between COVID-19 pandemic and six unhealthy eating behaviors

Researchers work to develop dual antigen COVID-19 vaccine candidate

More than 100 economies receive life-saving COVID-19 vaccines from COVAX

CD40 drug before surgery can benefit patients with early-stage pancreatic cancer

Broadly neutralizing antibodies show promise in preventing tick-borne encephalitis in mice

SFU mathematics professor to lead new infectious disease modeling network

Scientists compare DNA damaging properties of chemicals from vape products and cigarettes

Intermountain partners with University of Utah to jointly develop new medical educational program

New technique can make X-rays more efficient at diagnosing bone and other injuries

More new SARS-CoV-2 variants are highly likely

Study: H2AK119ub1 is necessary for maternal inheritance of H3K27me3

Solvation cages may lead to more efficient operation of high-voltage battery cells

Researchers develop innovative tough gel sheathed sutures inspired by human tendons

Addiction experts seek to understand why people engage in 'extreme' drinking

Phase II of Singapore's National Precision Medicine strategy to begin in April 2021

Urolithin A shows promise to slow progression of Duchenne Muscle Dystrophy

Phase 1 clinical study of unique vaccine to protect against COVID-19 begins

New wireless system can restore communication and mobility in people with paralysis

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News